ID
15640
Description
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Baseline 1st cycle Trial Medication
Link
https://clinicaltrials.gov/ct2/show/NCT02419378
Keywords
Versions (5)
- 8/13/15 8/13/15 - Martin Dugas
- 5/23/16 5/23/16 -
- 5/28/16 5/28/16 -
- 5/28/16 5/28/16 -
- 6/6/16 6/6/16 -
Uploaded on
June 6, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Baseline 1st cycle Trial Medication Multiple Sclerosis ALAIN01 NCT02419378
Baseline 1st cycle Trial Medication Multiple Sclerosis ALAIN01 NCT02419378
Description
Trial Medication RQG
Description
Date of Administration
Data type
date
Alias
- UMLS CUI [1,1]
- C1533734
- UMLS CUI [1,2]
- C0011008
Description
Trial Medication: Dose administered
Data type
float
Measurement units
- mg
Alias
- UMLS CUI [1]
- C3174092
Description
Trial Medication: Batch No
Data type
text
Alias
- UMLS CUI [1]
- C3641829
Description
Expiration
Data type
date
Alias
- UMLS CUI [1]
- C3669020
Description
Trial Medication: Reason if less than 12 mg
Data type
text
Alias
- UMLS CUI [1,1]
- C3174092
- UMLS CUI [1,2]
- C0392360
Similar models
Baseline 1st cycle Trial Medication Multiple Sclerosis ALAIN01 NCT02419378
C0947611 (UMLS CUI [1,2])
C1550373 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0243095 (UMLS CUI [1,2])
C0032976 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C1705848 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])